Skip to main content

Table 1 Demographic and health-related characteristics of study participants at entry to the trial

From: A feasibility study to prevent falls in older people who are sight impaired: the VIP2UK randomised controlled trial

Values are numbers (%) unless stated otherwise

Control (n = 16)

Home safety only (n = 16)

Home safety + Home exercise (n = 17)

Mean (SD) age (years)

80.8 (6.9)

81.4 (7.5)

82.1 (8.7)

Women (%)

12 (75)

12 (75)

8 (47)

Ethnicitya (%)

 White-British

16 (100.0)

14 (87.5)

16 (94.1)

 White-Irish

0 (0.0)

1 (6.2)

0 (0.0)

 White-Other

0 (0.0)

1 (6.2)

1 (5.9)

One or more fall(s) in previous 6 months (%)

8 (50)

6 (38)

1 (6)

Annualisedb fall rate per person at baseline by retrospective recall method (95 % CIs)

1.50 [0.78,2.62]

1.63 [0.87,2.78]

0.47 [0.13,1.20]

Mean (SD) number of medications

3.56 (2.42)

4.69 (3.00)

3.35 (2.18)

Takes psychotropic medication? (yes/no)

0

0

3 (18)

Lives alone

9 (56)

7 (44)

9 (53)

Does not follow home safety measures at baseline

7 (44)

7 (44)

7 (41)

Has not attended classes to improve fitness

11 (69)

10 (63)

12 (71)

Walks outside on own regularly

9 (56)

9 (56)

8 (47)

Uses walking aid to walk outside on own

4 (25)

7 (44)

8 (47)

Sight loss registered? (%)

 No

6 (38)

7 (44)

1 (6)

 Impaired

4 (24)

5 (31)

5 (29)

 Severe

6 (38)

4 (25)

11 (65)

Duration of visual impairment in years (%)

 0–6

3 (19)

2 (13)

2 (12)

 7–10

6 (38)

6 (38)

3 (17)

 11–20

2 (13)

5 (31)

5 (30)

 21–59

1 (6)

1 (6)

2 (12)

 60–92

0

1 (6)

2 (12)

 Missing

4 (24)

1 (6)

3 (17)

Baseline vision scores

 Visual acuity

  Mean (SD) logMAR scores

1.17 (0.31)

1.05 (0.37)

1.15 (0.29)

  Right eye/left eye

1.07 (0.37)

1.05 (0.35)

1.10 (0.33)

 Visual fields

  Mean (SD) scores

72.14 (28.11)

75.90 (22.12)

64.50 (28.73)

  Esterman test

n = 7 (44 %)

n = 10 (63 %)

n = 10 (59 %)

 Contrast sensitivity tests

  Mean (SD) scores

(1) Pelli-Robson

0.77 (0.38) n = 7

0.95 (0.40) n = 10

0.75 (0.44) n = 10

(2) MARS

0.95 (0.93) n = 9

0.77 (0.30) n = 6

0.71 (0.47) n = 7

Eye conditions (%)

 Age-related macular degeneration

8 (50)

12 (75)

8 (46)

 Glaucoma

3 (19)

2 (13)

2 (12)

 Myopic degeneration

2 (12)

0

1 (6)

 Diabetic retinopathy

0

1 (6)

0

 Other

0

0

3 (18)

 Missing

3 (19)

1 (6)

3 (18)

  1. aSelf-reported; bExact Poisson rate